For the first time, Food and Drug Administration has officially authorized a facility in North Carolina to begin producing a new, antibiotic-free influenza vaccine within the United States.
The announcement was made by Swiss pharmaceutical company Novartis, which will be operating the plant in Holly Springs, North Carolina. As noted in a press release, the operation will be the first of its kind in the US. Now that it’s been cleared by the FDA, the facility will be able to move forward with plans to manufacture seasonal cell-culture influenza vaccines.
Additionally, the plant will also have the capability of quickly ramping up vaccine production in the event of a pandemic.